Skip to content
Clinical Trials – home

AMMONIUM CHLORIDE BP: A Comprehensive Guide for Patients

0 / 2
trials open to patients / all trials
5+
Countries

In short

This article discusses recent clinical trials investigating the use of Ammonium Chloride BP, often combined with Diphenhydramine Hydrochloride BP, in the treatment of various types of lymphoma. These trials aim to evaluate the safety, efficacy, and potential benefits of this drug combination for patients with relapsed or refractory Hodgkin and non-Hodgkin lymphomas. The studies focus on different aspects of treatment, including dosage, administration methods, and combination with other therapies.

At a glance

Drug Combination
Ammonium Chloride BP and Diphenhydramine Hydrochloride BP
Lymphoma Types Studied
Hodgkin lymphoma, non-Hodgkin lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma
Patient Population
Adults with relapsed or refractory disease
Administration Methods
Intravenous infusion and oral routes
Primary Objectives
Safety, efficacy, maximum tolerated dose, pharmacokinetics, anti-tumor activity
Secondary Objectives
Quality of life impact, immune response, duration of response
Key Endpoints
Objective response rate, progression-free survival, overall survival, adverse events
Monitoring Focus
Vital signs, laboratory results, treatment-emergent adverse events, anti-drug antibodies

What is Ammonium Chloride BP?

Ammonium Chloride BP is a medication that is often used in combination with other drugs, particularly in the treatment of various types of lymphoma. The "BP" in its name stands for "British Pharmacopoeia," which indicates that it meets specific quality standards. This drug is also known by its chemical name, NH4Cl.

Medical Uses

While Ammonium Chloride BP itself is not a primary treatment for lymphoma, it is often used as part of a combination therapy or as a supportive medication. Its main uses in the context of lymphoma treatment include:

  • Supportive Care: It may be used to manage certain side effects of cancer treatments or to prepare patients for specific therapies.
  • Combination Therapy: Ammonium Chloride BP is frequently combined with other medications, such as Diphenhydramine Hydrochloride BP, to enhance overall treatment effectiveness.

It's important to note that this medication is not a direct treatment for lymphoma itself, but rather plays a supportive role in overall cancer care.

Administration

Ammonium Chloride BP can be administered in various ways, depending on the specific treatment plan and the patient's needs. Common routes of administration include:

  • Oral: It may be given as a tablet or solution to be taken by mouth.
  • Intravenous (IV): In some cases, it might be administered directly into the bloodstream through an IV line.

The dosage and frequency of administration will be determined by your healthcare provider based on your individual medical condition and treatment plan.

Potential Side Effects

As with any medication, Ammonium Chloride BP may cause side effects. It's important to discuss potential side effects with your healthcare provider. Some possible side effects may include:

  • Nausea or vomiting
  • Stomach discomfort
  • Changes in electrolyte balance

If you experience any severe or persistent side effects, contact your healthcare provider immediately.

Precautions and Considerations

When using Ammonium Chloride BP, there are several important considerations to keep in mind:

  • Medical History: Inform your doctor about your complete medical history, especially if you have kidney problems or liver disease.
  • Pregnancy and Breastfeeding: If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential risks and benefits with your healthcare provider.
  • Other Medications: Tell your doctor about all medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions.
  • Follow-up Care: Regular check-ups and blood tests may be necessary to monitor your response to treatment and manage any side effects.

Remember, Ammonium Chloride BP is typically used as part of a comprehensive treatment plan. Always follow your healthcare provider's instructions carefully and report any concerns or unusual symptoms promptly.

Questions people often ask

Conditions where Ammonium Chloride Bp is being studied

Each condition opens its own overview and trial list

Trials with Ammonium Chloride Bp

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).